These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24458176)

  • 1. Recurrent parathyroid carcinoma appearing as FDG negative but MIBI positive.
    Alabed YZ; Rakheja R; Novales-Diaz JA; Lisbona R
    Clin Nucl Med; 2014 Jul; 39(7):e362-4. PubMed ID: 24458176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
    Neumann DR; Esselstyn CB; Kim EY
    J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
    Gedik GK; Ata O; Karabagli P; Sari O
    Hell J Nucl Med; 2014; 17(3):214-7. PubMed ID: 25397627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distant subcutaneous recurrence of a parathyroid carcinoma: abnormal uptakes in the (99m)Tc-sestamibi scan and (18)F-FDG PET/CT imaging.
    Kim SS; Jeon YK; Lee SH; Kim BH; Kim SJ; Kim YK; Kim IJ
    Korean J Intern Med; 2014 May; 29(3):383-7. PubMed ID: 24851075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-anorectic parathyroid carcinoma with FDG-avid bone metastasis on PET/CT images.
    Li M; Lu H; Gao Y
    Clin Nucl Med; 2013 Nov; 38(11):916-8. PubMed ID: 24089062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.
    Traub-Weidinger T; Mayerhoefer ME; Koperek O; Mitterhauser M; Duan H; Karanikas G; Niederle B; Hoffmann M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4199-205. PubMed ID: 25029418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign Parathyroid Hyperplasia With Incidental Pulmonary Seeding on 99mTc-MIBI Scintigraphy and FDG PET/CT.
    Tsai YK; Tsai CJ; Chiu CH; Ko KH; Li YF
    Clin Nucl Med; 2022 Mar; 47(3):e329-e330. PubMed ID: 35025795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential false positive Tc-99m sestamibi parathyroid study due to uptake in brown adipose tissue.
    Wong KK; Brown RK; Avram AM
    Clin Nucl Med; 2008 May; 33(5):346-8. PubMed ID: 18431153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m pertechnetate/sestamibi imaging in a case of recurrent parathyroid carcinoma with metabolic bone disorder.
    Meng Z; Tan J; Zhang M; Dong F; Jia Q; Zhang F
    Clin Nucl Med; 2009 Jul; 34(7):479-82. PubMed ID: 19542965
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
    Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
    J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous Metastatic Breast Carcinoma and Parathyroid Adenoma on 18F-FDG PET/CT and 99mTc-Sestamibi Imaging.
    Singh H; Wale DJ; Wong KK; Gross MD; Viglianti BL
    Clin Nucl Med; 2019 Feb; 44(2):148-149. PubMed ID: 30418208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of [99mTC]MIBI and [18F]fluorodeoxyglucose for imaging recurrent medullary thyroid cancer and hyperparathyroidism in MEN 2a syndrome.
    Roelants V; Michel L; Lonneux M; Lacrosse M; Delgrange E; Donckier JE
    Acta Clin Belg; 2001; 56(6):373-7. PubMed ID: 11881324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
    Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
    Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of parathyroid carcinoma visualized on Tc-99m-sestamibi scintigraphy.
    Aigner RM; Fueger GF; Lax S
    Nuklearmedizin; 1997 Oct; 36(7):256-8. PubMed ID: 9394362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of thyroid-stimulating hormone on 18F-fluorodeoxyglucose and 99mTc-methoxyisobutylisonitrile uptake in human poorly differentiated thyroid cancer cells in vitro.
    Kim CH; Yoo IeR; Chung YA; Park YH; Kim SH; Sohn HS; Chung SK
    Ann Nucl Med; 2009 Feb; 23(2):131-6. PubMed ID: 19225935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
    Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m MIBI uptake in recurrent parathyroid carcinoma and brown tumors.
    Lu G; Shih WJ; Xiu JY
    J Nucl Med; 1995 May; 36(5):811-3. PubMed ID: 7738654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of late chest wall recurrence of breast carcinoma during Tc-99m sestamibi parathyroid scintigraphy.
    Conrad GR; Sloan DA; Sinha P
    Clin Nucl Med; 2003 May; 28(5):408-9. PubMed ID: 12702942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.